Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Gehring

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Journal of Virology|September 19, 2008
Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoireAnthony Tanoto Tan, Elisabetta Loggi, Carolina Boni, et al.
Hepatology (Baltimore, Md.)|April 17, 2024
Neutralizing antibodies to interferon alfa arising during peginterferon therapy of chronic hepatitis B in children and adults: Results from the HBRN TrialsMuhammad Atif Zahoor, Joshua B Feld, Hsing-Hua Sylvia Lin, et al.
Journal of Hepatology|March 8, 2022
Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infectionAdam J Gehring, Patricia Mendez, Kirsten Richter, et al.
Journal of Viral Hepatitis|October 27, 2022
Hepatitis C virus-specific immune responses following direct-acting antivirals administered during recent hepatitis C virus infectionJulia L Casey, Gregory J Dore, Jason Grebely, et al.
The Journal of Clinical Investigation|January 3, 2023
Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cellsShirin Nkongolo, Deeqa Mahamed, Adrian Kuipery, et al.
JHEP Reports : Innovation in Hepatology|April 20, 2026
Persistent Loss of Intrahepatic IFN-γ in HBV Is Linked to Selective Impairment of Liver-Resident CXCR6+NK Cells Despite Long-Term NUC TherapyBoris J B Beudeker, Diren Arda Karaoglu, Shirin Nkongolo, et al.
The Journal of Infectious Diseases|June 7, 2024
B-Cell Activation Gene Signature in Blood and Liver of Hepatitis B e Antigen-Positive Patients With Immune Active Chronic Hepatitis BZgjim Osmani, Boris J B Beudeker, Zwier M A Groothuismink, et al.
Journal of Hepatology|October 14, 2014
Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patientWaseem Qasim, Maurizia Brunetto, Adam J Gehring, et al.
Hepatology Communications|December 6, 2023
IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis BConan Chua, Loghman Salimzadeh, Ann T Ma, et al.
The Journal of Clinical Investigation|April 15, 2025
Virus-associated inflammation imprints an inflammatory profile on monocyte-derived macrophages in the human liverJuan Diego Sanchez Vasquez, Shirin Nkongolo, Daniel Traum, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Journal of Virology|September 19, 2008
Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoireAnthony Tanoto Tan, Elisabetta Loggi, Carolina Boni, et al.
Hepatology (Baltimore, Md.)|April 17, 2024
Neutralizing antibodies to interferon alfa arising during peginterferon therapy of chronic hepatitis B in children and adults: Results from the HBRN TrialsMuhammad Atif Zahoor, Joshua B Feld, Hsing-Hua Sylvia Lin, et al.
Journal of Hepatology|March 8, 2022
Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infectionAdam J Gehring, Patricia Mendez, Kirsten Richter, et al.
Journal of Viral Hepatitis|October 27, 2022
Hepatitis C virus-specific immune responses following direct-acting antivirals administered during recent hepatitis C virus infectionJulia L Casey, Gregory J Dore, Jason Grebely, et al.
The Journal of Clinical Investigation|January 3, 2023
Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cellsShirin Nkongolo, Deeqa Mahamed, Adrian Kuipery, et al.
JHEP Reports : Innovation in Hepatology|April 20, 2026
Persistent Loss of Intrahepatic IFN-γ in HBV Is Linked to Selective Impairment of Liver-Resident CXCR6+NK Cells Despite Long-Term NUC TherapyBoris J B Beudeker, Diren Arda Karaoglu, Shirin Nkongolo, et al.
The Journal of Infectious Diseases|June 7, 2024
B-Cell Activation Gene Signature in Blood and Liver of Hepatitis B e Antigen-Positive Patients With Immune Active Chronic Hepatitis BZgjim Osmani, Boris J B Beudeker, Zwier M A Groothuismink, et al.
Journal of Hepatology|October 14, 2014
Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patientWaseem Qasim, Maurizia Brunetto, Adam J Gehring, et al.
Hepatology Communications|December 6, 2023
IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis BConan Chua, Loghman Salimzadeh, Ann T Ma, et al.
The Journal of Clinical Investigation|April 15, 2025
Virus-associated inflammation imprints an inflammatory profile on monocyte-derived macrophages in the human liverJuan Diego Sanchez Vasquez, Shirin Nkongolo, Daniel Traum, et al.
Pageof 9